OTC Markets OTCPK - Delayed Quote USD

BML, Inc. (BMLKF)

Compare
20.30
0.00
(0.00%)
As of April 8 at 4:00:00 PM EDT. Market Open.
Loading Chart for BMLKF
  • Previous Close 0.00
  • Open --
  • Bid 16.84 x --
  • Ask 21.84 x --
  • Day's Range --
  • 52 Week Range 12.68 - 20.30
  • Volume --
  • Avg. Volume 28
  • Market Cap (intraday) 791.834M
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) 18.97
  • EPS (TTM) 1.07
  • Earnings Date May 9, 2025
  • Forward Dividend & Yield 0.67 (3.29%)
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est --

BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures. It also provides medical information system services, which include electronic medical charts for networking medical information, as well as preventive medicine services. In addition, the company offers food sanitation test, including food sanitation control and food processing services, which comprise contract services for microorganism testing of raw materials, and prepared and processed food; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and wastewater tests; work environment services, such as measurement of ethylene oxide gas, formaldehyde, organic solvent, and dust; environmental monitoring, which include measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; human genome analysis services; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.

www.bml.co.jp

4,513

Full Time Employees

March 31

Fiscal Year Ends

Recent News: BMLKF

View More

Performance Overview: BMLKF

Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

BMLKF
10,737.35%
Nikkei 225 (^N225)
20.51%

1-Year Return

BMLKF
3,780.20%
Nikkei 225 (^N225)
20.26%

3-Year Return

BMLKF
735.59%
Nikkei 225 (^N225)
17.52%

5-Year Return

BMLKF
220.39%
Nikkei 225 (^N225)
63.93%

Compare To: BMLKF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BMLKF

View More

Valuation Measures

Annual
As of 4/8/2025
  • Market Cap

    750.91M

  • Enterprise Value

    285.20M

  • Trailing P/E

    18.93

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.81

  • Price/Book (mrq)

    0.90

  • Enterprise Value/Revenue

    0.30

  • Enterprise Value/EBITDA

    4.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.30%

  • Return on Assets (ttm)

    3.51%

  • Return on Equity (ttm)

    4.87%

  • Revenue (ttm)

    141.33B

  • Net Income Avi to Common (ttm)

    6.08B

  • Diluted EPS (ttm)

    1.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    66.42B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BMLKF

View More

Company Insights: BMLKF

Research Reports: BMLKF

View More

People Also Watch